Influnce of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers

Biopharmaceutics and Drug Disposition

Volumn 23, Issue 2, 2002, Pages 77-81

  Kang, Byoung C ^a   Yang, Chang Q ^a   Cho, Hae K ^b   Suh, Ok K ^a   Shin, Wan G ^a  

^a Seoul National University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

Drug interaction; Fluconazole; Healthy volunteers; Omeprazole; Pharmacokinetics

Indexed keywords

CYTOCHROME P450 2C19; CYTOCHROME P450 3A4; FLUCONAZOLE; OMEPRAZOLE; ANTIFUNGAL AGENT; ANTIULCER AGENT;

ADULT; AREA UNDER THE CURVE; ARTICLE; CATALYSIS; CHEMICAL REACTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; HUMAN; HYDROXYLATION; LIVER METABOLISM; MALE; PROTEIN DEGRADATION; VOLUNTEER; CLINICAL TRIAL; DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ADULT; ANTI-ULCER AGENTS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; FLUCONAZOLE; HUMANS; MALE; OMEPRAZOLE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0036000063     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.291     Document Type: Article

References (27)

1. The influence of gastric pH on the pharmacokinetics of fluconazole: The effect of omeprazole
2. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydoxylase, P4502C19
3. Effects of the antifungal agents on oxidative drug metabolism
4. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes
5. Azoles, allylamines and drug metabolism
6. Effect of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture
7. Midazolam hydroxylation by human liver microsomes in vitro: Inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents
8. Effect of azole antifungals on human microsomal metabolism of diclofenac and midazolam
9. Comparative effects of imidazole antifungals on liver monooxygenases
10. Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals
11. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of wafarin by fluconazole: In vitro studies
12. Fluconazole: A potent inhibitor of cytochrome P450-depedent drug-metabolism in mice and humans in vivo. Comparative study with ketoconazole
13. Fluconazole alters terfenadine pharmacokinetics and electrocardiographic pharmacodynamics
14. The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of itravenous and oral midazolam
15. Effect of fluconazole dose on the extent of fluconazole-triazolam interaction
16. Antifungals
17. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: Relation to pharmacokinetic interactions in vivo
18. Inhibition of triazolam hydroxylation by ketoconazole, itraconazole, hydoxyitraconazole and fluconazole in-vitro
19. Rifampin, Dexamethasone, and Omeprazole
20. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes
21. Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of s-mephenytoin
22. Omeprazole drug interaction studies
23. High-performance liquid chromatographic determination of lansoprazole and its metabolites in human serum and urine
24. Critical evaluation of potential error in pharmacokinetic studies using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
25. Pharmacokinetics of diazepam following multiple dose oral administration to healthy human subjects
26. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction
27. Effect of omeprazole - A gastric proton pump inhibitor- on pentagastrin stimulated acid secretion in man